EUVIMEDEUVIMED entdecken
Open Access

Calibrating a functional assay for variant classification in RYR1 -related malignant hyperthermia susceptibility

Evan Z Ying iD, Amber Douglass, Marwan A Hawari, Linda Groom, Kathryn Stowell, Robert T Dirksen, Jennifer J Johnston iD, Leslie G Biesecker iD

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Evan Z Ying und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, 50 South Drive, Bethesda, MD 20892, Un…. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Malignant Hyperthermia, Genetic Predisposition to Disease. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Identifying individuals with pathogenic variants for RYR1-related Malignant Hyperthermia Susceptibility (MHS) could reduce morbidity and mortality due to MH reactions. Realization of this goal requires knowledge of variant pathogenicity, and proper weighting of functional assays is important for accurate variant classification. Caffeine-induced Ca2+ release assays can be used to support pathogenicity per the ClinGen Variant Curation Expert Panel (VCEP). However, the caffeine-induced Ca2+ release assay lacks formal validation with known pathogenic and benign variants.

Methods

Fifteen benign/likely benign and six pathogenic/likely pathogenic RYR1 variants were used to calibrate the caffeine-induced Ca2+ release assay using a multi-mode microplate reader. Five variants of unknown significance (VUS) were assayed for possible reclassification.

Results

Our data support use of the caffeine-induced Ca2+ release assay at a moderate weight per the American College of Medical Genetics and Genomics pathogenicity criteria schema with a positive likelihood ratio of 12.14:1 (pathogenicity) and a negative likelihood ratio of 0.22:1 (4.5:1 benignity). Using this validated assay, two of five VUS were reclassified as likely benign.

Conclusion

Formal validation of the caffeine-induced Ca2+ release assay supports the VCEP functional criteria weighting at moderate strength based on these data. Additional variants should be assayed to shift more from VUS to benign or pathogenic classifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelMalignant HyperthermiaGenetic Predisposition to DiseaseHumansCaffeineCalciumGenetic Variation

Stichwörter der Autor:innen

Calcium Release AssayMalignant Hyperthermia SusceptibilityRYR1Variant Classification

Substanzen

Ryanodine Receptor Calcium Release ChannelRYR1 protein, humanCaffeineCalcium

Autor:innen und Institutionen

  • Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, 50 South Drive, Bethesda, MD 20892, United States.
  • Department of Microbiology Immunology and Tropical Medicine, The George Washington University, 2300 I St. NW, Washington, DC 20037, United States.
  • Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, United States.
  • School of Food Technology and Natural Sciences, Massey University, Tennent Drive, Palmerston North 4410, New Zealand.

ORCID-Profile: Evan Z Ying, Jennifer J Johnston, Leslie G Biesecker

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health, National Human Genome Research Institute
  • National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Ying, E. Z., Douglass, A., Hawari, M. A., Groom, L., Stowell, K., Dirksen, R. T., Johnston, J. J., & Biesecker, L. G. (2025). Calibrating a functional assay for variant classification in RYR1 -related malignant hyperthermia susceptibility. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf038

Vancouver

Ying EZ, Douglass A, Hawari MA, Groom L, Stowell K, Dirksen RT, et al. Calibrating a functional assay for variant classification in RYR1 -related malignant hyperthermia susceptibility. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf038

BibTeX
@article{Ying2025,
  author = {Ying, Evan Z and Douglass, Amber and Hawari, Marwan A and Groom, Linda and Stowell, Kathryn and Dirksen, Robert T and Johnston, Jennifer J and Biesecker, Leslie G},
  title = {Calibrating a functional assay for variant classification in RYR1 -related malignant hyperthermia susceptibility},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf038}
}
Kostenlos starten →